跳至主要内容
临床试验/NCT04717245
NCT04717245已完成不适用

Comparative Study : The Effect of Vaginal Estrogen Use, Fractional CO2 LASER and Microablative Fractional Radiofrequency in the Treatment of Vaginal Atrophy: Clinical, Histological, Immunohistochemical and Molecular Biology Study

University of Sao Paulo General Hospital1 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2018年10月25日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
75
试验地点
1
主要终点
Life's quality questionnaire

研究概览

简要总结

Postmenopausal hypoestrogenism may determine genital atrophy, which may be accompanied by a non-specific inflammatory process and may hinder or even prevent sexual intercourse. In more severe cases, the patient may have local pain that interferes with their daily activities. The best treatment for increasing genital trophism is still estrogen. However, there are women who can not use this therapy or do not want it. Therefore, there is a need for alternatives, such as ablation techniques: use of CO2 LASER and fractional radiofrequency.

The study was carried out at the outpatient clinic of Lower Genital Tract ambulatory of the Discipline of Gynecology, Department of Obstetrics and Gynecology, Clinical Hospital, Faculty of Medicine, University of São Paulo, involving 75 women who were divided after randomization in three groups:

Group 1 - treatment with topical vaginal promestriene (n = 25 patients); Group 2 - treatment with fractional CO2 LASER (n = 25 patients); Group 3 - fractional microablative radiofrequency treatment (n = 25 patients).

An evaluation of the complaints were be performed through questionnaires on sexuality, quality of life and urinary incontinence, as well as biopsies of the vaginal wall for histomorphometric, immunohistochemical and molecular biology study before and after six months of treatment. The duration of the study were fifteen months.

详细描述

After completing the eligibility criteria, patients signed the consent inform.

Division of groups:

Were included in the study 75 patients, divided into three groups:

Group 1 - Treatment with topical vaginal promestriene - 25 patients in this group were included patients free of systemic or topical hormonal treatment for at 3 months

Group 2 - Treatment with CO2 LASER - 25 patients, in this group were included patients free of systemic or topical hormonal treatment for at 3 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age equal or superior to 40 years and under 65 years
  • Clinical menopause - last menstrual period from 1 to 5 years from the date of recruitment
  • FSH measurement> 25 IU / ml, estrogen <20 æg / ml
  • Patients with vaginal atrophy and clinical and / or sexual symptoms
  • Patients without hormonal treatment for at least five years

排除标准

  • Whole Hymen
  • Altered oncology cytology of the cervix and / or vagina
  • Vaginal infections
  • Connective tissue diseases
  • Immunosuppression
  • Coagulation change
  • Diabetes Mellitus
  • Thyroid diseases
  • Use of systemic or local feminine hormones
  • Use of other substances with estrogenic properties

研究组 & 干预措施

Fractional CO2 LASER

Active Comparator

Vaginal fractional CO2 LASER 3 sessions applications

干预措施: Fractional CO2 LASER (Other)

Microablative fractional radiofrequency

Active Comparator

Vaginal Microablative fractional radiofrequency 3 sessions application

干预措施: Microablative Fractional radiofrequency (Other)

Promestriene Vaginal

Active Comparator

Promestriene vaginal use during 3 months

干预措施: Promestriene Vaginal (Drug)

结局指标

主要结局

Life's quality questionnaire

时间窗: 3-4 months

It was acessed at the beginnig and in the end of the treatment. We used the Short Form Health Survey 36 questionnaire for this parameter. It contains 36 items measuring eight dimensions, that vary the pontuation between 1-5 to 1-6. All but one of the 36 items are used to score the SF-36 eight domains that are aggregated in two summary measures, Physical and Mental components. Among the eight domains, three scales (Physical Functioning, Role-Physical, and Bodily Pain) contributes mostly to the Physical Component Summary (PCS) and three (Mental Health, Role-Emotional, and Social Functioning) contributes to the Mental Component Summary. The domains Vitality, General Health, and Social Functioning present noteworthy correlations with both summary componentNormalized scores below 50 are interpreted as below the generals population. The better is to have a higher pontuation.

次要结局

  • Sexuality questionnaire - Female Sexual Function Index(3-4 months)
  • score symptoms(3-4 months)
  • pH values(3-4 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Comparative Study: Vaginal Promestriene Use,... | 临床试验